Previsioni di mercato dei modelli di fegato umano in Nord America fino al 2028 – Impatto del COVID-19 e analisi regionale per tipo (organoidi di fegato, fegato su chip, modelli 2D, biostampa 3D e altri), applicazione (scoperta di farmaci, formazione e altri) ) e utente finale (aziende farmaceutiche e biotecnologiche, istituti di ricerca e altri)
TIPRE00026113 |
Pages: 98 |
Biotechnology |
Nov 2021
|
Type: Regional |
Status: Published
Si prevede che il mercato dei modelli di fegato umano in Nord America crescerà da 98.522,08 migliaia di dollari nel 2021 a 2.08.998,55 migliaia di dollari entro il 2028; si stima che crescerà a un CAGR dell\'11,3% dal 2021 al 2028.\\n\\nStati Uniti, Canada e Messico sono economie del Nord America. Si prevede che la crescente prevalenza di malattie del fegato alimenterà la crescita del mercato dei modelli di fegato umano in Nord America. Il fegato è l\'organo interno più grande del corpo e svolge oltre 500 funzioni. La tossicità epatica è una delle principali preoccupazioni nella valutazione del rischio poiché il fegato è esposto alla maggior parte dei composti xenobiotici e ai loro metaboliti bioattivi, rendendolo suscettibile alle malattie epatiche indotte chimicamente. Il virus dell’epatite C (HCV), il virus dell’epatite cronica B (HBV), la steatosi epatica non alcolica (NAFLD) e la malattia epatica associata all’alcol (ALD) sono tra le principali cause di malattia epatica cronica. L’epatite virale continua a essere la principale causa di morte per insufficienza epatica e, allo stesso tempo, la NAFLD è diventata uno dei fattori che contribuiscono in più rapida crescita alla morbilità epatica e alla mortalità associata. Le malattie epatiche croniche come la NAFLD o le infezioni da epatite cronica sono associate a un rischio elevato di cancro primario al fegato e carcinoma epatocellulare (HCC). La cirrosi è ben nota ed è la principale causa di HCC, con un\'incidenza di circa 0,5 milioni e 5 tasso di sopravvivenza a un anno del 10%. Secondo recenti stime, l’incidenza di questo tumore è aumentata a un ritmo allarmante, rendendo l’HCC il quinto tumore più comune negli uomini e il settimo tumore più comune nelle donne. Il cancro al fegato rappresenta il 5,6% di tutti i tumori umani, aumentando così il peso nel 2020. L’HCC è noto per essere la seconda causa principale di decessi correlati al cancro nella regione. Altri tipi di cancro al fegato sono il carcinoma colangiocellulare (CCC), una malattia maligna del dotti biliari del fegato ed epatoblastoma. L\'epatoblastoma è il tumore maligno del fegato più comune nei bambini. Pertanto, un aumento della prevalenza delle malattie del fegato, comprese le malattie croniche e acute e le infezioni microbiche, aumenta la domanda di modelli di fegato in tutta la regione del Nord America. \\n\\nSecondo i Centri per il controllo e la prevenzione delle malattie (CDC), i pazienti con malattia epatica cronica o immunocompromessi corrono un rischio maggiore di malattie gravi da COVID-19. Il rapido aumento dei casi di COVID-19 segnalati negli Stati Uniti ha reso necessari cambiamenti diffusi nelle pratiche sanitarie in tutto il Paese. Sebbene il trapianto di organi rappresenti spesso un\'emergenza medica, la crescente domanda e l\'utilizzo di risorse ospedaliere ha influito negativamente sulla capacità dei centri trapianti di eseguire queste procedure salvavita. I problemi legati al COVID-19 hanno ostacolato il trapianto di fegato nella regione, rappresentando una minaccia per il mercato dei modelli di fegato umano nel periodo previsto. \\n\\nCon le nuove funzionalità e tecnologie, i fornitori possono attrarre nuovi clienti ed espandere la propria presenza nei mercati emergenti. È probabile che questo fattore guidi il mercato dei modelli di fegato umano in Nord America. Si prevede che il mercato dei modelli di fegato umano in Nord America crescerà a un buon CAGR durante il periodo di previsione. \\n\\nEntrate e previsioni del mercato dei modelli di fegato umano del Nord America fino al 2028 (migliaia di dollari)\\n\\nSegmentazione del mercato dei modelli di fegato umano del Nord America\\nMercato dei modelli di fegato umano del Nord America per tipo\\n- Organoidi di fegato\\n- Fegato su- a-chip\\n- Modelli 2D\\n- Biostampa 3D\\n- Altri\\nMercato dei modelli di fegato umano in Nord America per applicazione\\n- Scoperta di farmaci\\n- Formativi\\n- Altro\\nMercato dei modelli di fegato umano in Nord America per utente finale\\ n- Aziende farmaceutiche e biotecnologiche\\n- Istituti di ricerca \\n- Altri \\nMercato dei modelli di fegato umano in Nord America, per Paese\\n- Stati Uniti \\n- Canada \\n- Messico \\nMercato dei modelli di fegato umano in Nord America -Società citate\\n- BioIVT\\n- CELLINK\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- MIMETAS BV\\n- ORGANOVO HOLDINGS INC.\\n- THERMO FISHER SCIENTIFIC INC.\\n\\n
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Liver Models Market By Type
1.3.2 North America Human Liver Models Market By Application
1.3.3 North America Human Liver Models Market By End User
1.3.4 North America Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Liver Models Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Diseases
5.1.2 Increasing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Expensive Liver Models
5.3 Market Opportunities
5.3.1 Escalating Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Surging Technology Advancements in Organ Printing.
5.5 Impact analysis
6. Human Liver Models Market North America Analysis
6.1 North America Human Liver Models Market Revenue Forecast and Analysis
7. North America Human Liver Models Market Analysis By Type
7.1 Overview
7.2 North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. North America Human Liver Models Market Analysis By Application
8.1 Overview
8.2 North America Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. North America Human Liver Models Market Analysis By End User
9.1 Overview
9.2 North America Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. North America Human Liver Models Market Country Analysis
10.1 North America: Human Liver Models Market
10.1.1 Overview
10.1.2 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 US: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.1.3 US: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.1.4 US: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.2 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 Canada: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.2.3 Canada: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.2.4 Canada: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.3 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 Mexico: Human Liver Models Market, by Type 20192028 (US$ Thousand)
10.1.2.3.3 Mexico: Human Liver Models Market, by Application 20192028 (US$ Thousand)
10.1.2.3.4 Mexico: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on North America Human Liver Models Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MIMETAS BV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 InSphero
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioIVT
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CELLINK
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 inancial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Kerafast
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ORGANOVO HOLDINGS INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. US: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Human Liver Models Market Segmentation
Figure 2. North America Human Liver Models Market Segmentation, By Country
Figure 3. North America Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. North America Human Liver Models Market Revenue Forecast and Analysis
Figure 9. North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. North America Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. North America 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. North America 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. North America Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. North America Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. North America Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. North America Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. North America Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. North America Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. North America Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. North America: Human Liver Models Market, by Key Country Revenue (2021) (US$ Thousand)
Figure 24. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Liver Models Market By Type
1.3.2 North America Human Liver Models Market By Application
1.3.3 North America Human Liver Models Market By End User
1.3.4 North America Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Liver Models Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Diseases
5.1.2 Increasing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Expensive Liver Models
5.3 Market Opportunities
5.3.1 Escalating Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Surging Technology Advancements in Organ Printing.
5.5 Impact analysis
6. Human Liver Models Market North America Analysis
6.1 North America Human Liver Models Market Revenue Forecast and Analysis
7. North America Human Liver Models Market Analysis By Type
7.1 Overview
7.2 North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. North America Human Liver Models Market Analysis By Application
8.1 Overview
8.2 North America Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. North America Human Liver Models Market Analysis By End User
9.1 Overview
9.2 North America Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. North America Human Liver Models Market Country Analysis
10.1 North America: Human Liver Models Market
10.1.1 Overview
10.1.2 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 US: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.1.3 US: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.1.4 US: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.2 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 Canada: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.2.3 Canada: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.2.4 Canada: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.3 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 Mexico: Human Liver Models Market, by Type 20192028 (US$ Thousand)
10.1.2.3.3 Mexico: Human Liver Models Market, by Application 20192028 (US$ Thousand)
10.1.2.3.4 Mexico: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on North America Human Liver Models Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MIMETAS BV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 InSphero
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioIVT
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CELLINK
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 inancial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Kerafast
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ORGANOVO HOLDINGS INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. US: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Human Liver Models Market Segmentation
Figure 2. North America Human Liver Models Market Segmentation, By Country
Figure 3. North America Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. North America Human Liver Models Market Revenue Forecast and Analysis
Figure 9. North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. North America Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. North America 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. North America 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. North America Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. North America Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. North America Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. North America Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. North America Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. North America Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. North America Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. North America: Human Liver Models Market, by Key Country Revenue (2021) (US$ Thousand)
Figure 24. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
1. BioIVT
2. CELLINK
3. Emulate, Inc.
4. InSphero
5. Kerafast
6. MIMETAS BV
7. ORGANOVO HOLDINGS INC.
8. THERMO FISHER SCIENTIFIC INC.
2. CELLINK
3. Emulate, Inc.
4. InSphero
5. Kerafast
6. MIMETAS BV
7. ORGANOVO HOLDINGS INC.
8. THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America human liver models market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America human liver models market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Related Reports
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000